365 related articles for article (PubMed ID: 26905343)
1. Nigella sativa and its active constituent thymoquinone in oral health.
Al-Attass SA; Zahran FM; Turkistany SA
Saudi Med J; 2016 Mar; 37(3):235-44. PubMed ID: 26905343
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.
Gholamnezhad Z; Havakhah S; Boskabady MH
J Ethnopharmacol; 2016 Aug; 190():372-86. PubMed ID: 27364039
[TBL] [Abstract][Full Text] [Related]
3. A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases.
Samarghandian S; Farkhondeh T; Samini F
CNS Neurol Disord Drug Targets; 2018; 17(6):412-420. PubMed ID: 29962349
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone a Potential Therapeutic Molecule from the Plant Nigella sativa: Role of Colloidal Carriers in its Effective Delivery.
Negi P; Rathore C; Sharma G; Singh B; Katare OP
Recent Pat Drug Deliv Formul; 2018; 12(1):3-22. PubMed ID: 29189187
[TBL] [Abstract][Full Text] [Related]
5. Review: Nigella sativa (Prophetic Medicine): A Review.
Ijaz H; Tulain UR; Qureshi J; Danish Z; Musayab S; Akhtar MF; Saleem A; Khan KK; Zaman M; Waheed I; Khan I; Abdel-Daim M
Pak J Pharm Sci; 2017 Jan; 30(1):229-234. PubMed ID: 28603137
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed.
Agbaria R; Gabarin A; Dahan A; Ben-Shabat S
Drug Des Devel Ther; 2015; 9():3119-24. PubMed ID: 26124636
[TBL] [Abstract][Full Text] [Related]
7. The standardized extract of Nigella sativa and its major ingredient, thymoquinone, ameliorates angiotensin II-induced hypertension in rats.
Enayatfard L; Mohebbati R; Niazmand S; Hosseini M; Shafei MN
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):51-58. PubMed ID: 30269105
[TBL] [Abstract][Full Text] [Related]
8. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome.
Razavi BM; Hosseinzadeh H
J Endocrinol Invest; 2014 Nov; 37(11):1031-40. PubMed ID: 25125023
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone and its therapeutic potentials.
Darakhshan S; Bidmeshki Pour A; Hosseinzadeh Colagar A; Sisakhtnezhad S
Pharmacol Res; 2015; 95-96():138-58. PubMed ID: 25829334
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of chemoprotective enzymes and glutathione by Nigella sativa (black seed) and thymoquinone in CCl4-intoxicated rats.
El-Sayed WM
Int J Toxicol; 2011 Dec; 30(6):707-14. PubMed ID: 21994235
[TBL] [Abstract][Full Text] [Related]
11. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy.
Mahmoud YK; Abdelrazek HMA
Biomed Pharmacother; 2019 Jul; 115():108783. PubMed ID: 31060003
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of Nigella sativa oil and thymoquinone attenuates long term cisplatin treatment induced toxicity and oxidative damage in rat kidney.
Farooqui Z; Shahid F; Khan AA; Khan F
Biomed Pharmacother; 2017 Dec; 96():912-923. PubMed ID: 29223554
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic perspectives of the black cumin component thymoquinone: A review.
Sarkar C; Jamaddar S; Islam T; Mondal M; Islam MT; Mubarak MS
Food Funct; 2021 Jul; 12(14):6167-6213. PubMed ID: 34085672
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review.
Majdalawieh AF; Fayyad MW
Int Immunopharmacol; 2015 Sep; 28(1):295-304. PubMed ID: 26117430
[TBL] [Abstract][Full Text] [Related]
15. The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases.
Fatima Shad K; Soubra W; Cordato DJ
Clin Exp Pharmacol Physiol; 2021 Nov; 48(11):1445-1453. PubMed ID: 34297870
[TBL] [Abstract][Full Text] [Related]
16. Validated high-performance thin-layer chromatographic method for the quantification of thymoquinone in Nigella Sativa extracts and formulations.
Velho-Pereira RM; Barhate CR; Kulkarni SR; Jagtap AG
Phytochem Anal; 2011; 22(4):367-73. PubMed ID: 21337651
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review.
Sadeghi E; Imenshahidi M; Hosseinzadeh H
Mol Biol Rep; 2023 Jun; 50(6):5439-5454. PubMed ID: 37155017
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone, a major constituent in Nigella sativa seeds, is a potential preventative and treatment option for atherosclerosis.
Majdalawieh AF; Yousef SM; Abu-Yousef IA
Eur J Pharmacol; 2021 Oct; 909():174420. PubMed ID: 34391767
[TBL] [Abstract][Full Text] [Related]
19. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance.
Dajani EZ; Shahwan TG; Dajani NE
J Physiol Pharmacol; 2016 Dec; 67(6):801-817. PubMed ID: 28195061
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice.
Hosseinzadeh H; Parvardeh S
Phytomedicine; 2004 Jan; 11(1):56-64. PubMed ID: 14971722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
